Expert Analysis

3rd Circ. Decision Sheds Light On BIPA Bank Exemption

The Third Circuit's recent decision in McGoveran v. Amazon illuminates how courts are extending the Illinois Biome... (more story)

Data Reveals Pivot In Feds' Financial Fraud Priorities

Recent Justice Department data shows fraud prosecutions fell to their lowest rate in a decade in 2025, illustratin... (more story)

New Timeline For Benefits Cases May Increase FCA Litigation

Recent reforms designed to speed enforcers’ intervention decisions in False Claims Act suits involving state-admin... (more story)

Deals & Corporate Governance More

Taxation With Representation: Sidley, Paul Weiss, Kirkland

In this week's Taxation With Representation, Germany's Merck KGaA acquires life sciences tools supplier Bio-Techne Corp., drugmaker AbbVie buys clinical-stage biotechnology company Apogee Therapeutics, and bui... (more story)

4th Circ. Says Supply Co.'s Foreign Member Kills Diversity

The Fourth Circuit on Thursday declined to reinstate a medical supply company's contract dispute against a U.K. corporation over COVID-19 test kits, after finding that the lack of a U.S. citizen on the supply ... (more story)

11th Circ. Urged To Toss Convictions In $1.4B Hospital Fraud

Two brothers convicted in a $1.4 billion scheme to bill insurers inflated rates for drug tests told the Eleventh Circuit on Wednesday that there was insufficient evidence to support their convictions and that ... (more story)

A Midyear Look At Antiterrorism Act Jurisprudence And Policy

Plaintiffs have filed comparably fewer new actions under the Antiterrorism Act this year, though a handful of key decisions further defined the statute’s aiding-and-abetting standard and highlighted continuing... (more story)

Cassava Investors Ink $31M Drug Suit Deal Alongside Appeal

Cassava Sciences investors have asked a Texas federal judge to preliminarily approve a $31 million settlement that ends their claims the pharmaceutical company inflated its stock prices with misleading informa... (more story)

FTC Requires Fix For Aurobindo's $250M Lannett Deal

The Federal Trade Commission is allowing Aurobindo Pharma Ltd. to move ahead with its planned $250 million acquisition of Lannett Co. Inc., after the pharmaceutical company agreed to unload four generic drug p... (more story)

Digital Health & Technology More

Meta Fails To Knock Out BIPA Voiceprint Privacy Claims

A California federal judge has refused to let Meta Platforms Inc. escape an Illinois woman's proposed class claims that Meta collects "voiceprints" in violation of Illinois' Biometric Information Privacy Act, ... (more story)

Steps For Employers After 7th Circ. BIPA Retroactivity Ruling

The Seventh Circuit's recent ruling in Clay v. Union Pacific sharply limits per-scan statutory damages theories in pending Biometric Information Privacy Act cases by retroactively applying a 2024 amendment, bu... (more story)

Planned Parenthood Sent Patient Data To Google, Suit Says

Planned Parenthood and regional affiliates were hit with a proposed class action alleging they use hidden tracking tools on their website and patient portals to transmit sensitive sexual and reproductive healt... (more story)

Stryker Says Data Breach Suit Built On Speculation

Michigan-based medical technology company Stryker Corp. has asked a federal judge to toss a proposed class action over a March cyberattack, arguing the former and current employees suing the company cannot sho... (more story)

Wellstar Reaches Deal In Patient Data-Sharing Suit

Georgia's largest healthcare system has reached a settlement with a group of anonymous patients who alleged that the confidential health information of "millions" was shared with Meta Platform Inc. without con... (more story)

Eli Lilly Weight Drug TM Deal Too Secretive, Ind. Judge Says

An Indiana federal judge on Thursday refused to sign off on a confidential settlement that would bar a telehealth company from selling knock-offs of Eli Lilly's weight-loss medications, saying the companies di... (more story)

Policy & Compliance More

5 ERISA Cases To Keep An Eye On In The Second Half Of 2026

A U.S. Supreme Court challenge to Intel Corp.'s 401(k) investment lineup tops the list of cases benefits attorneys will be watching this summer and fall, though appeals involving health plan tobacco fees, plan... (more story)

High Court To Issue Big Decisions In Term's Final Days

As the U.S. Supreme Court enters the final days of its term, the justices still have several major decisions to issue, including some concerning birthright citizenship, the president's power to remove independ... (more story)

Sandoz Still Can't Escape Generics Claims From GM, Others

A Pennsylvania federal judge on Thursday declined to rethink her decision forcing Sandoz's Swiss parent company to face generic-drug price-fixing claims from major employers like American Airlines Inc. and Gen... (more story)

Texas Faces Tough Questions In Tylenol Autism Appeal

A Texas appellate court seemed skeptical Thursday of an argument that the parent entities of the company that sells Tylenol should have to defend claims that the pain reliever causes autism, suggesting that th... (more story)

Netflix Urges Justices Not To Disturb 9th Circ. ERISA Docs Ruling

Netflix urged the U.S. Supreme Court Thursday not to take up a petition from an employee health plan participant who alleged the company failed to provide him access to plan documents in violation of federal b... (more story)

Wash. Therapist Seeks Bar On 'Conversion Therapy' Ban

A Washington therapist has urged a federal court to bar the state from enforcing its ban on what is commonly known as conversion therapy, arguing that a U.S. Supreme Court decision this year has "vindicated" h... (more story)